These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16445798)

  • 1. Thalidomide, semen distribution, teratogenicity... and cost.
    Laffitte E
    Br J Dermatol; 2006 Mar; 154(3):563; author reply 563-4. PubMed ID: 16445798
    [No Abstract]   [Full Text] [Related]  

  • 2. [Thalidomide].
    Laffitte E; Revuz J
    Ann Dermatol Venereol; 2000; 127(6-7):603-13. PubMed ID: 10930858
    [No Abstract]   [Full Text] [Related]  

  • 3. Thalidomide.
    Radomsky CL; Levine N
    Dermatol Clin; 2001 Jan; 19(1):87-103. PubMed ID: 11155589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infertility and teratogenicity after paternal exposure to systemic dermatologic medications: A systematic review.
    Zakhem GA; Motosko CC; Mu EW; Ho RS
    J Am Acad Dermatol; 2019 Apr; 80(4):957-969. PubMed ID: 30287313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacology of thalidomide.
    Trapnell CB
    AIDS Clin Care; 1998 Jan; 10(1):3, 8. PubMed ID: 11365075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo formation of dihydroxylated and glutathione conjugate metabolites derived from thalidomide and 5-Hydroxythalidomide in humanized TK-NOG mice.
    Yamazaki H; Suemizu H; Shimizu M; Igaya S; Shibata N; Nakamura M; Chowdhury G; Guengerich FP
    Chem Res Toxicol; 2012 Feb; 25(2):274-6. PubMed ID: 22268628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paternal exposure and counselling: experience of a Teratology Information Service.
    De Santis M; Cesari E; Cavaliere A; Ligato MS; Nobili E; Visconti D; Caruso A
    Reprod Toxicol; 2008 Sep; 26(1):42-6. PubMed ID: 18598753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The revival of thalidomide: an old drug with new indications].
    Laffitte E
    Rev Prat; 2006 Nov; 56(18):1977-83. PubMed ID: 17274497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thalidomide-related headache.
    Phan A; Favrole P; Alamowitch S; Chosidow O
    Dermatology; 2009; 218(3):285. PubMed ID: 18832813
    [No Abstract]   [Full Text] [Related]  

  • 10. Thalidomide in rabbit semen.
    Lutwak-Mann C; Schmid K; Keberle H
    Nature; 1967 Jun; 214(5092):1018-20. PubMed ID: 6055395
    [No Abstract]   [Full Text] [Related]  

  • 11. New cases of thalidomide embryopathy in Brazil.
    Schuler-Faccini L; Soares RC; de Sousa AC; Maximino C; Luna E; Schwartz IV; Waldman C; Castilla EE
    Birth Defects Res A Clin Mol Teratol; 2007 Sep; 79(9):671-2. PubMed ID: 17676592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of dermatologic drugs in pregnancy and lactation.
    Leachman SA; Reed BR
    Dermatol Clin; 2006 Apr; 24(2):167-97, vi. PubMed ID: 16677965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unlocking a dark past.
    Rodríguez-Pérez F; Rape M
    Elife; 2018 Sep; 7():. PubMed ID: 30252647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase II, pharmacokinetic, and biologic study of semaxanib and thalidomide in patients with metastatic melanoma.
    Mita MM; Rowinsky EK; Forero L; Eckhart SG; Izbicka E; Weiss GR; Beeram M; Mita AC; de Bono JS; Tolcher AW; Hammond LA; Simmons P; Berg K; Takimoto C; Patnaik A
    Cancer Chemother Pharmacol; 2007 Feb; 59(2):165-74. PubMed ID: 16736151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Teratogenicity: any relationship to carcinogenicity?
    Neubert D
    IARC Sci Publ; 1980; (27):169-78. PubMed ID: 7439963
    [No Abstract]   [Full Text] [Related]  

  • 16. Enantioselectivity of thalidomide serum and tissue concentrations in a rat glioma model and effects of combination treatment with cisplatin and BCNU.
    Murphy S; Boyle FM; Davey RA; Gu XQ; Mather LE
    J Pharm Pharmacol; 2007 Jan; 59(1):105-14. PubMed ID: 17227627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thalidomide and misoprostol: Ophthalmologic manifestations and associations both expected and unexpected.
    Miller MT; Ventura L; Strömland K
    Birth Defects Res A Clin Mol Teratol; 2009 Aug; 85(8):667-76. PubMed ID: 19639653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I and pharmacokinetic study of oral thalidomide in patients with advanced hepatocellular carcinoma.
    Shiah HS; Chao Y; Chen LT; Yao TJ; Huang JD; Chang JY; Chen PJ; Chuang TR; Chin YH; Whang-Peng J; Liu TW
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):654-64. PubMed ID: 16520988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of thalidomide in chicken embryos.
    Stephens TD
    Birth Defects Res A Clin Mol Teratol; 2009 Aug; 85(8):725-31. PubMed ID: 19645049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Commentary: paternal legacies.
    Anderson D; Jenkinson PC; Edwards AJ; Hughes JA; Brinkworth MH
    Teratog Carcinog Mutagen; 1999; 19(2):105-8. PubMed ID: 10332807
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.